Search Results 1491-1500 of 15054 for transexamic
Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/ ...
Bloody urine · decreased amount of urine · increased blood pressure · increased thirst · loss of appetite · lower back or side pain · nausea · pale skin ...
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation ( ...
The purpose of this study is to collect blood and tissue samples from patients with and without cancer to evaluate laboratory tests for early cancer detection ...
Researchers at Mayo Clinic Comprehensive Cancer Center have implemented a new germline testing method using hair follicle DNA extraction, which enhances ...
The purpose of this study is to establish whether therapeutic-dose parenteral anticoagulation improves outcomes (reduces intubation or mortality) by 30 days ...
For oral dosage form (tablets):. For non-small cell lung cancer: Adults—100 milligrams (mg) once a day. Your doctor may adjust your dose as needed and tolerated ...
Testosterone is a male hormone responsible for the growth and development of the male sex organs and maintenance of secondary sex characteristics. This medicine ...
This medicine may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention.
Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer. Head Neck. 2022 Dec; 44(12):2760-2768.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.